Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,299 | 37 | 92.2% |
| Education | $109.93 | 2 | 7.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $291.46 | 7 | $0 (2024) |
| Nevro Corp. | $219.19 | 2 | $0 (2019) |
| UCB, Inc. | $218.04 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $180.05 | 6 | $0 (2024) |
| Lilly USA, LLC | $87.31 | 4 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $63.68 | 3 | $0 (2024) |
| PFIZER INC. | $60.02 | 3 | $0 (2024) |
| Janssen Biotech, Inc. | $58.68 | 2 | $0 (2018) |
| Incyte Corporation | $47.19 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $36.09 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $766.28 | 22 | UCB, Inc. ($218.04) |
| 2023 | $140.26 | 2 | ABBVIE INC. ($124.99) |
| 2021 | $26.15 | 1 | AbbVie Inc. ($26.15) |
| 2020 | $42.74 | 2 | AbbVie Inc. ($22.32) |
| 2019 | $289.54 | 6 | Nevro Corp. ($198.62) |
| 2018 | $77.96 | 3 | Janssen Pharmaceuticals, Inc ($28.27) |
| 2017 | $65.79 | 3 | Janssen Biotech, Inc. ($32.53) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.32 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $27.66 | General |
| 10/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $30.50 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.90 | General |
| Category: Dermatology | ||||||
| 09/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $94.66 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/23/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Immunology | ||||||
| 09/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $36.09 | General |
| Category: Immunology | ||||||
| 08/27/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: DERMATOLOGY | ||||||
| 08/20/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: DERMATOLOGY | ||||||
| 07/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.16 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Immunology | ||||||
| 05/30/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug), JUBLIA, ARAZLO | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Dermatology | ||||||
| 05/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.82 | General |
| Category: IMMUNOLOGY | ||||||
| 05/22/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Immunology | ||||||
| 04/30/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.29 | General |
| Category: Dermatology | ||||||
| 04/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: DERMATOLOGY | ||||||
| 03/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: DERMATOLOGY | ||||||
| 01/08/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $166.66 | General |
| Category: Immunology | ||||||
| 04/10/2023 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 03/02/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,437 | 2,180 | $558,027 | $162,127 |
| 2022 | 12 | 1,476 | 2,163 | $531,303 | $155,000 |
| 2021 | 14 | 1,626 | 2,401 | $553,184 | $172,228 |
| 2020 | 18 | 1,465 | 2,235 | $484,423 | $138,796 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 222 | 259 | $59,624 | $29,395 | 49.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 259 | 296 | $68,968 | $20,969 | 30.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 146 | 146 | $50,224 | $12,760 | 25.4% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 115 | 125 | $39,007 | $11,935 | 30.6% |
| 17000 | Destruction of skin growth | Office | 2021 | 161 | 202 | $39,727 | $10,671 | 26.9% |
| 12032 | Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | Office | 2021 | 25 | 25 | $32,225 | $7,917 | 24.6% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 126 | 638 | $12,122 | $4,487 | 37.0% |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | Office | 2021 | 14 | 16 | $10,339 | $2,710 | 26.2% |
| 11104 | Punch biopsy of single skin lesion | Office | 2021 | 17 | 17 | $7,242 | $2,251 | 31.1% |
| 11603 | Removal of malignant growth (2.1 to 3.0 centimeters) of the trunk, arms, or legs | Office | 2021 | 14 | 14 | $7,903 | $2,036 | 25.8% |
| 11602 | Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs | Office | 2021 | 14 | 14 | $7,021 | $1,810 | 25.8% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 16 | 23 | $5,198 | $1,296 | 24.9% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 11 | 11 | $2,640 | $582.16 | 22.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 513 | 684 | $153,900 | $39,695 | 25.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 212 | 258 | $56,024 | $26,511 | 47.3% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 134 | 144 | $45,361 | $12,157 | 26.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 104 | 142 | $46,718 | $11,111 | 23.8% |
| 12032 | Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | Office | 2020 | 31 | 31 | $38,026 | $9,100 | 23.9% |
| 17000 | Destruction of skin growth | Office | 2020 | 121 | 145 | $27,960 | $7,089 | 25.4% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2020 | 12 | 15 | $7,260 | $4,627 | 63.7% |
| 12034 | Repair of wound (7.6 to 12.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | Office | 2020 | 14 | 14 | $16,605 | $4,390 | 26.4% |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | Office | 2020 | 22 | 25 | $17,112 | $3,786 | 22.1% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 101 | 565 | $10,170 | $3,476 | 34.2% |
| 11602 | Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs | Office | 2020 | 22 | 26 | $13,541 | $3,404 | 25.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 41 | 41 | $13,530 | $3,207 | 23.7% |
About Roger Lee, M D PHD
Roger Lee, M D PHD is a Dermatology healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2008. The National Provider Identifier (NPI) number assigned to this provider is 1538318704.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Roger Lee, M D PHD has received a total of $1,409 in payments from pharmaceutical and medical device companies, with $766.28 received in 2024. These payments were reported across 39 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,299).
As a Medicare-enrolled provider, Lee has provided services to 6,004 Medicare beneficiaries, totaling 8,979 services with total Medicare billing of $628,151. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Palo Alto, CA
- Active Since 09/12/2008
- Last Updated 06/04/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1538318704
Products in Payments
- Senza Spinal Cord Stimulation System (Device) $219.19
- Bimzelx (Biological) $218.04
- DUPIXENT (Biological) $167.36
- RINVOQ (Biological) $156.15
- SKYRIZI (Biological) $114.61
- TALTZ (Drug) $65.41
- OPZELURA (Drug) $47.19
- EUCRISA (Drug) $44.75
- SILIQ (Drug) $42.76
- Sotyktu (Drug) $36.09
- GUSELKUMAB (Biological) $32.53
- Otezla (Drug) $30.50
- INVOKANA (Drug) $28.27
- VTAMA (Drug) $26.51
- Tremfya (Drug) $26.15
- OLUMIANT (Drug) $21.90
- Cabtreo (Drug) $20.92
- Humira (Biological) $20.70
- COSENTYX (Biological) $20.42
- CIBINQO (Drug) $15.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Palo Alto
John Doux, M.d, M.D
Dermatology — Payments: $124,944
Joyce Teng, Md, MD
Dermatology — Payments: $115,109
Shireen Guide, Md, MD
Dermatology — Payments: $79,371
Ilka Netravali, Md, MD
Dermatology — Payments: $28,025
Dr. Daniel Navi, M.d, M.D
Dermatology — Payments: $19,065
Dr. Thomas Hoffman, M.d, M.D
Dermatology — Payments: $17,860